Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Adult alcoholism and attention-deficit hyperactivity disorder are connected

15.10.2003


  • Attention-deficit hyperactivity disorder (ADHD) symptoms include inattention, motor hyperactivity and impulsiveness.
  • Researchers have found a distinct phenotype or "profile" of adults with co-existing ADHD and alcoholism.
  • ADHD is five to 10 times more frequent among adult alcoholics than among the normal population.

Investigation of the serotonin transporter gene (5-HTT) and the 5-HT2c receptor Cys23Ser polymorphism does not support a genetic commonality of ADHD and alcoholism.

Attention-deficit hyperactivity disorder (ADHD) symptoms include inattention, motor hyperactivity and impulsiveness. Roughly half of the adults who report ADHD symptoms also report a co-existing substance-abuse disorder. New findings published in the October issue of Alcoholism: Clinical & Experimental Research have identified a distinct phenotype or "profile" of individuals with co-existing ADHD and alcoholism. Although prior studies have suggested a genetic commonality of ADHD and alcoholism, the study found no significant contribution of two specific candidate genes, the promoter polymorphism of the serotonin transporter gene (5-HTT) and the 5-HT2c receptor Cys23Ser polymorphism.



"Our results indicate that individuals with persisting ADHD symptoms in adulthood seem to be at high risk of developing an alcohol-use disorder," said Monika Johann, medical doctor and research associate at the University of Regensburg and first author of the study. "Moreover, there is evidence for a highly increased severity of alcohol dependence in subjects with ADHD."

Researchers examined 314 adult alcoholics (262 males, 52 females) as well as 220 unrelated healthy control subjects, all of German descent. Each participant was assessed for psychiatric disorders, such as substance-use disorders (including alcoholism), ADHD, and antisocial personality disorder (APD). Patients with a history of major psychiatric disorders, including depression and schizophrenia, and those with addictions to drugs other than alcohol and nicotine, were excluded from the investigation. Genotyping was performed without knowledge of diagnostic status, with a focus on the 5-HTT promoter and the 5-HT2c Cys23Ser polymorphism.

"Prior neuroendocrine challenge studies with a drug called fenfluramine in subjects with ADHD or alcoholism revealed similar differences in the serotonergic neurotransmission when compared to normal subjects," explained Johann. "The usual response to fenfluramine administration is a measurable increase in the circulating prolactin. This usual increase is blunted in subjects with ADHD or alcoholism. The main structures responsible for the fenfluramine-induced prolactin release are the 5-HTT and the 5-HT2c receptors. Therefore, both seemed plausible as overlapping sources of genetic liability of ADHD and alcoholism."

Neither of them, however, appear to be genetic risk factors in the sample examined. "Our data demonstrate that the 5-HTT promoter and the 5-HT2c Cys23Ser polymorphism do not contribute to the putative common genetic predisposition for ADHD and alcohol dependence," said Johann. "However, several other candidate genes have yet to be investigated."

Nonetheless, the findings do indicate a distinct phenotype, a way to measure an observable trait or behavior. Adult alcoholics with ADHD had a significantly higher daily and record intake of alcohol per month, an earlier age of onset of alcohol dependence, a higher frequency of thoughts about suicide, a greater number of court proceedings, and a greater occurrence of APD.

Thus, despite the lack of support for a common genetic predisposition, "the data show once again that to have ADHD means to be at high risk for developing alcohol dependence," said Ema Loncarek, a medical doctor and clinician at the psychiatric clinic of the University of Regensburg. Loncarek works on a ward for illegal drug addiction, providing detoxification and therapy.

"Dr. Johann’s findings of a phenotype are very close to what we see in drug addicts with ADHD, and what has been described before by other authors. We see on a regular basis that drug addicts with ADHD are difficult to handle. They start to abuse drugs earlier than other people, change earlier to "hard" drugs, take longer to start treatment, and take longer to successfully finish therapy."

Johann described in more detail the phenotypic variations she and her colleagues found. "Within this group of alcoholics, subjects with ADHD in adulthood are five to 10 times more frequent than in the normal population," she said. "Compared to alcoholics without ADHD, alcoholics with ADHD in adulthood were at least four years younger at onset of alcoholism, drank about 50 grams pure alcohol more per day during the previous month, had a nearly twofold higher rate of first-degree positive family history of alcoholism, had a nearly three times higher frequency of antisocial personality disorder, had a nearly seven times higher frequency of court proceedings, and had a more than two times higher frequency of suicidal thoughts."

Both Johann and Loncarek spoke of a need for the development and evaluation of specialized treatment programs that address "phenotypical specifics" as well as co-existing disorders such as alcoholism and ADHD. While pharmacological remedies, they noted, have been extensively evaluated for the treatment of ADHD in childhood, little attention has been given to substance-abusing individuals with ADHD in adulthood."

"ADHD seems to be highly underestimated in adulthood," said Johann, "yet seems to be an important risk factor for the development of alcohol dependence."


###
Alcoholism: Clinical & Experimental Research (ACER) is the official journal of the Research Society on Alcoholism and the International Society for Biomedical Research on Alcoholism. Co-authors of the ACER paper included Gabriela Bobbe, Albert Putzhammer, and Norbert Wodarz of the University of Regensburg. The study was partially funded by the University of Regensburg.

Monika Johann | EurekAlert!
Further information:
http://www.uni-regensburg.de/
http://www.alcoholism-cer.com/

More articles from Health and Medicine:

nachricht Millions through license revenues
27.04.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht New High-Performance Center Translational Medical Engineering
26.04.2017 | Fraunhofer ITEM

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>